{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:15:42Z","timestamp":1793301342108,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.iac.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T19:15:17Z","timestamp":1381173317000},"page":"181-196","source":"Crossref","is-referenced-by-count":99,"title":["Mastocytosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Melody C.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirsh D.","family":"Komarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2013.09.001_bib1","series-title":"World Health Organization (WHO) classification of tumours. Pathology & genetics: tumours of haematopoietic and lymphoid tissues","first-page":"54","article-title":"Mastocytosis","author":"Horny","year":"2008"},{"issue":"5","key":"10.1016\/j.iac.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4049\/jimmunol.146.5.1410","article-title":"Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells","volume":"146","author":"Kirshenbaum","year":"1991","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.iac.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"issue":"1\u20134","key":"10.1016\/j.iac.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000235339","article-title":"Early development of mast cells","volume":"94","author":"Rottem","year":"1991","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"8","key":"10.1016\/j.iac.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.V84.8.2489.2489","article-title":"Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+\/Fc epsilon RI- cell population","volume":"84","author":"Rottem","year":"1994","journal-title":"Blood"},{"issue":"4 Pt 2","key":"10.1016\/j.iac.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0625.1995.tb00250.x","article-title":"Mast cell ontogeny and apoptosis","volume":"4","author":"Metcalfe","year":"1995","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2010.031690","article-title":"Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis","volume":"96","author":"Wilson","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2567.2003.01559.x","article-title":"Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene","volume":"108","author":"Sundstrom","year":"2003","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.iac.2006.05.002","article-title":"Diagnostic evaluation and classification of mastocytosis","volume":"26","author":"Valent","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2007.05.024","article-title":"KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1\/PDGFRA-associated chronic eosinophilic leukemia are distinct entities","volume":"120","author":"Maric","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000154858","article-title":"Regulatory effects of histamine and histamine receptor expression in human allergic immune responses","volume":"94","author":"Akdis","year":"2008","journal-title":"Chem Immunol Allergy"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11588890-000000000-00000","article-title":"Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations","volume":"12","author":"Castells","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib15","first-page":"197","article-title":"Systemic mastocytosis: current concepts and treatment advances","volume":"3","author":"Tefferi","year":"2004","journal-title":"Curr Hematol Rep"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/187152806775269303","article-title":"Current options in the treatment of mast cell mediator-related symptoms in mastocytosis","volume":"5","author":"Escribano","year":"2006","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.iac.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archderm.1963.01590140008002","article-title":"The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases","volume":"87","author":"Caplan","year":"1963","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mjd.2003.98","article-title":"Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology","volume":"48","author":"Brockow","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archderm.138.6.785","article-title":"Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease","volume":"138","author":"Brockow","year":"2002","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.iac.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0016-5085(88)80012-X","article-title":"Gastrointestinal dysfunction in systemic mastocytosis. A prospective study","volume":"95","author":"Cherner","year":"1988","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.05.026","article-title":"Gastrointestinal manifestations in\u00a0mastocytosis: a study of 83 patients","volume":"132","author":"Sokol","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/1523-1747.ep12468899","article-title":"Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital","volume":"96","author":"Horan","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(05)70298-7","article-title":"Gastrointestinal abnormalities and involvement in systemic mastocytosis","volume":"14","author":"Jensen","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000046642","article-title":"Cytogenetic and molecular genetic abnormalities in systemic mastocytosis","volume":"107","author":"Gupta","year":"2002","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/gut.17.2.107","article-title":"Gastrointestinal involvement in systemic mastocytosis","volume":"17","author":"Ammann","year":"1976","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2214\/ajr.103.2.405","article-title":"Gastrointestinal lesions in mastocytosis","volume":"103","author":"Clemett","year":"1968","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"5 Pt 1","key":"10.1016\/j.iac.2013.09.001_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0016-5085(82)80263-1","article-title":"A\u00a0new syndrome of symptomatic cutaneous mastocytoma producing vasoactive intestinal polypeptide","volume":"82","author":"Wesley","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iac.2013.09.001_bib30","first-page":"126","article-title":"Mastocytosis presenting as a skeletal disorder","volume":"16","author":"Delsignore","year":"1996","journal-title":"Iowa Orthop J"},{"issue":"5","key":"10.1016\/j.iac.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients' perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00002517-199109000-00013","article-title":"Effect of major axial skeleton trauma on preexisting lumbosacral spondylolisthesis","volume":"4","author":"Floman","year":"1991","journal-title":"J\u00a0Spinal Disord"},{"issue":"8","key":"10.1016\/j.iac.2013.09.001_bib34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jbmr.5650050811","article-title":"Osteoporosis as the sole presentation of bone marrow mastocytosis","volume":"5","author":"Lidor","year":"1990","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.iac.2013.09.001_bib35","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase\u2013a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib36","first-page":"4","article-title":"Pathology of the lymph node and spleen in systemic mast cell disease","volume":"1","author":"Travis","year":"1988","journal-title":"Mod Pathol"},{"issue":"4 Pt 1","key":"10.1016\/j.iac.2013.09.001_bib37","first-page":"1163","article-title":"Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases","volume":"22","author":"Mican","year":"1995","journal-title":"Hepatology"},{"issue":"3 Pt 1","key":"10.1016\/j.iac.2013.09.001_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0091-6749(88)90015-2","article-title":"A\u00a0survey of the number and distribution of mast cells in the skin of patients with mast cell disorders","volume":"82","author":"Garriga","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archderm.1987.01660260075017","article-title":"Mast cell numbers in diffuse scleroderma","volume":"123","author":"Nishioka","year":"1987","journal-title":"Arch Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.iac.2013.09.001_bib40","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0091-6749(86)90240-X","article-title":"Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells","volume":"78","author":"Elias","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2133.1986.tb02780.x","article-title":"Increase in skin mast cells following chronic house dust mite exposure","volume":"114","author":"Mitchell","year":"1986","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2013.09.001_bib42","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1610-0387.2010.07482.x","article-title":"Mastocytosis\u2013an update","volume":"8","author":"Amon","year":"2010","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000083954","article-title":"Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes","volume":"136","author":"Florian","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2011.192","article-title":"Immunophenotyping in systemic mastocytosis diagnosis: \u2018CD25 positive\u2019 alone is more informative than the \u2018CD25 and\/or CD2\u2019 WHO criterion","volume":"25","author":"Morgado","year":"2012","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.iac.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/PAS.0b013e318078ce7a","article-title":"Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis","volume":"31","author":"Hahn","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.iac.2013.09.001_bib47","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.iac.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0091-6749(90)90067-E","article-title":"Cromolyn sodium in the management of systemic mastocytosis","volume":"85","author":"Horan","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-6749(83)90098-2","article-title":"Intervention with epinephrine in hypotension associated with mastocytosis","volume":"71","author":"Turk","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000245681","article-title":"Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis","volume":"195","author":"Godt","year":"1997","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00414106","article-title":"Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes","volume":"277","author":"Czarnetzki","year":"1985","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.iac.2013.09.001_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.1991.01680020059005","article-title":"Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids","volume":"127","author":"Guzzo","year":"1991","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.iac.2013.09.001_bib54","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1001\/archderm.1985.01660120042017","article-title":"Treatment of urticaria pigmentosa with corticosteroids","volume":"121","author":"Barton","year":"1985","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib55","first-page":"54","article-title":"Mastocytosis with malabsorption, myelofibrosis, and massive ascites","volume":"82","author":"Reisberg","year":"1987","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.iac.2013.09.001_bib56","first-page":"1471","article-title":"A\u00a0retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis","volume":"35","author":"Chen","year":"1994","journal-title":"J\u00a0Nucl Med"},{"issue":"8","key":"10.1016\/j.iac.2013.09.001_bib57","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjmed.2011.02.038","article-title":"Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis","volume":"124","author":"Laroche","year":"2011","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.iac.2013.09.001_bib58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ajh.23459","article-title":"Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management","volume":"88","author":"Pardanani","year":"2013","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.iac.2013.09.001_bib59","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2133.1998.02131.x","article-title":"Response of severe systemic mastocytosis to interferon alpha","volume":"138","author":"Butterfield","year":"1998","journal-title":"Br J Dermatol"},{"issue":"13","key":"10.1016\/j.iac.2013.09.001_bib61","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.iac.2013.09.001_bib62","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.21561","article-title":"Cytoreductive therapy in 108 adults with systemic mastocytosis: outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine","volume":"84","author":"Lim","year":"2009","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.iac.2013.09.001_bib63","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.leukres.2008.12.020","article-title":"Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis","volume":"33","author":"Vega-Ruiz","year":"2009","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib64","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.iac.2013.09.001_bib65","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.iac.2013.09.001_bib66","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","article-title":"Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation","volume":"106","author":"Gotlib","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.iac.2013.09.001_bib67","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.21894","article-title":"Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study","volume":"85","author":"Paul","year":"2010","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.iac.2013.09.001_bib68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2362.2008.02036.x","article-title":"Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis","volume":"38","author":"Aichberger","year":"2008","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.bmt.1705245","article-title":"A\u00a0pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis","volume":"37","author":"Nakamura","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.iac.2013.09.001_bib70","first-page":"94","article-title":"Splenectomy in the management of systemic mast cell disease","volume":"107","author":"Friedman","year":"1990","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1468-3083.2004.00830.x","article-title":"Cutaneous mastocytosis in children: a clinical analysis of 71 cases","volume":"18","author":"Kiszewski","year":"2004","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib72","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1371\/journal.pone.0001906","article-title":"Phenotypic and genotypic characteristics of mastocytosis according to the age of onset","volume":"3","author":"Lanternier","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.iac.2013.09.001_bib73","first-page":"320","article-title":"Pediatric cutaneous mastocytosis: a review of 180 patients","volume":"7","author":"Ben-Amitai","year":"2005","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"10.1016\/j.iac.2013.09.001_bib74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/0377-4929.101761","article-title":"Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22)","volume":"55","author":"Gadage","year":"2012","journal-title":"Indian J Pathol Microbiol"},{"issue":"8","key":"10.1016\/j.iac.2013.09.001_bib75","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1097\/MPH.0b013e3182329b80","article-title":"Myelomastocytic leukemia with t(8;21) in a 3-year-old child","volume":"33","author":"Intzes","year":"2011","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.iac.2013.09.001_bib76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MPH.0b013e318063ef26","article-title":"Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states","volume":"29","author":"Lee","year":"2007","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.iac.2013.09.001_bib77","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pbc.23026","article-title":"Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia","volume":"57","author":"Mahadeo","year":"2011","journal-title":"Pediatr Blood Cancer"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856113000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856113000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:25:52Z","timestamp":1688516752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856113000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0889856113000647"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2013.09.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}